Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania
- PMID: 19323805
- PMCID: PMC2667529
- DOI: 10.1186/1756-0500-2-49
Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania
Abstract
Background: Antimicrobial resistance is fast becoming a global concern with rapid increases in multidrug-resistant Gram negative organisms. The prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates increases the burden on implementing infectious disease management in low socio-economic regions. As incidence can vary widely between regions, this study was done to determine resistance patterns of Gram-negative organisms at Bugando Medical Center, a tertiary hospital in Mwanza, Tanzania.
Methods: A total of 800 clinical samples (urine, wound swab, pus, blood, aspirate, sputum etc) were processed over a period of 6 months. Gram-negative bacteria were identified using conventional in-house biochemical tests and susceptibility to common antibiotics done using disc diffusion methods. The disc approximation method was used to identify ESBL producers.
Results: A total of 377 Gram-negative bacteria (GNB) recovered from 377 clinical specimens were analyzed of which 76.9% were Enterobacteriaceae. Among all GNB, 110/377 (29.2%) were found to be ESBL producers. Species specific ESBLs rate among Klebsiella pneumoniae, Escherichia coli, Acinetobacter spp, Proteus spp and other enterobacteria were 63.7%, 24.4%, 17.7%, 6.4% and 27.9% respectively. A statistically significant higher number of inpatients 100/283 (35.3%) compared to 10/94 (10.6%) of outpatients had ESBL-producing organisms (p = 0.000023). Rates of resistances to gentamicin, tetracycline, sulphamethaxazole/trimethoprim and ciprofloxacin were significantly higher among ESBLs isolates than non-ESBL isolates (p = 0.000001).
Conclusion: ESBL producing organisms are common at BMC (Bugando Medical Center) and pose a challenge to antibiotic therapy. Successful implementation of a routine detection of ESBL production is essential in designing appropriate antibiotic prescribing policies and infection control intervention programmes.
References
-
- Yoichi HM, Junichi M, Yoshitsugu K, Shimeru K, Sayoko M, Yukihisa O, Yasuo N, Nobuhiko H, Yasuyoshi I, Matsuhisa T, John B, Jan J, Ronald K. Regional variation in the prevalence of extended-spectrum β-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998–2002) Diag Microbiol and Infect Dis. 2005;52:323–329. doi: 10.1016/j.diagmicrobio.2005.04.004. - DOI - PubMed
-
- Mendes C, Hsiung A, Kiffer C, Oplustil C, Sinto S, Mimica I, Zaccoli C. Evaluation of the in vitro activity of 9 antimicrobial against bacterial strains isolated from patients in intensive care units in Brazil. MYSTIC Antimicrobial Surveillance program. Braz J Infect Dis. 2000;4:236–244. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
